Associate Professor of Neurology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University; staff neurologist, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
Daniel Ontaneda, MD, PhD: Central Vein Sign as Potential Multiple Sclerosis Biomarker
June 25th 2020The neurologist at Cleveland Clinic’s Mellen Center for Multiple Sclerosis and co-principal investigator of the CAVS-MS study details the specific reasons for examining central vein sign as a biomarker.